GLK-321 mid dose BID

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisNCT07400965Glaukos CorporationPhase 2Recruiting2026-09Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.